| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |